Buying a new pharmacy will allow Hims & Hers to expand into new markets. Hims & Hers (HIMS -1.11%) recently acquired a pharmacy that will expand the company's product line and lower costs. This is the second major vertical integration for the company, and in this video Travis Hoium shows how it will continue to drive growth. *Stock prices used were end-of-day prices of Sept. 16, 2024. The video was published on Sept. 16, 2024. ...

Hims & Hers Health, Inc. (HIMS) ended the recent trading session at $16.28, demonstrating a -1.75% swing from the preceding day's closing price. The stock fell short of the S&P 500, which registered a gain of 0.13% for the day. Meanwhile, the Dow experienced a rise of 0.55%, and the technology-dominated Nasdaq saw a decrease of 0.52%. The company's stock has climbed by 6.35% in the past month, exceeding the Medical sector's gain of 3.34% and the S&P 500's gain of 3.67%. The investment community will be payi ...

The healthcare company will be making more of the product it sells. Shares of healthcare company Hims & Hers Health (HIMS 2.85%) jumped as much as 23.9% this week after news of closing a large acquisition. According to data provided by S&P Global Market Intelligence, shares are up 18.3% for the week as of 2:30 p.m. ET. Hims & Hers gets deeper into compounding The biggest news was Hims & Hers issuing 976,341 shares of common stock to acquire Nivagen Pharmaceuticals, which does business as MedisourceRX. The c ...

Shares of Hims & Hers are falling even as the company has been posting some solid results. Hims & Hers Health (HIMS 4.01%) has built its brand up in recent years by focusing on offering its customers products related to sensitive issues such as hair loss and erectile dysfunction. And it is looking at other opportunities, such as weight loss, that can accelerate its already high rate of growth. This can make it a potentially exciting stock for growth investors to hold in their portfolios. But despite the opp ...

Telemedicine was one of the most in-demand services during the height of the COVID-19 pandemic. In early 2020, people around the world experienced a life-changing event as the COVID-19 pandemic struck. One of the biggest byproducts of that crisis was a near-overnight shift from the office to work from home. This dynamic followed social-distancing protocols issued by the Centers for Disease Control and Prevention (CDC). With many in the general population adopting this new way of working, it wasn't long befo ...

Traders are often quoted as slaves to volatility, as their entire business model is dependent on stocks moving actively to meet the conditions of a trade and spread. However, long-term value investors are just as dependent on volatility as their distant day-trader counterparts. Here's why. NXE Volatility, as measured by the volatility index (VIX), can bring fear and uncertainty to the stock market, and with those feelings usually come lower prices. So, before they allocate capital, those hunting for a poten ...

Hims & Hers Health, Inc.'s (HIMS) investors are encountering some short-term losses from the stock of late. Shares of the San Francisco, CA-based health and wellness platform have plunged 32.1% in the past three months, underperforming the industry's 11.4% gain. In the same time frame, the stock underperformed the sector and S&P 500's 4.7% and 2.7% growth, respectively. Two major developments from HIMS in recent months include the announcement of its second-quarter 2024 results (in August) and the addition ...

Sales growth could accelerate now that it provides lower-cost, weight-management drugs. If you'd like to become a billionaire, paying attention to how other billionaires invest is a sensible way to get started. Everyday investors can easily keep tabs on billionaire stock purchases because the U.S. Securities and Exchange Commission (SEC) makes them disclose their trading activity every three months. In the latest round of disclosures, it's clear that a handful of funds run by billionaire investors bought sh ...

These businesses are rapidly growing profits and cash flows. You don't need to have a ton of cash on hand to invest. Steadily investing even modest amounts of money and distributing that capital across various stocks through thick and thin in the market can help you compound your returns with time. It's important to understand the business behind any stock you buy. While the recent market volatility is making some investors fearful of putting cash to work, if you have a more modest amount, like $200, you ca ...

A new threat from Eli Lilly pushed the stock lower. Shares of Hims & Hers Health (HIMS 0.61%), the online, direct-to-consumer pharmacy, were pulling back this week as investors feared that pharmaceutical companies could start encroaching on its territory. In particular, Eli Lilly (LLY -0.92%), the maker of popular GLP-1 drugs like Mounjaro, said on Tuesday that it would discount single-dose vials of its Zepbound GLP-1 weight loss drug in response to high demand. The news was seen as a competitive threat to ...